http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 27 Jul 2026 12:15:15 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html <p>Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.</p><p>MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.</p><p>Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.</p><p>The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.</p> http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html Mon, 27 Jul 2026 12:15:15 -0400 BRKR GRAL ILMN MDXH NEO NTRA PACB TECH TEM http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html <p>Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.</p><p>MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.</p><p>Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.</p><p>The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.</p> http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html Mon, 27 Jul 2026 12:15:15 -0400 BRKR GRAL ILMN MDXH NEO NTRA PACB TECH TEM http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html <p>Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.</p><p>MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.</p><p>Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.</p><p>The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.</p> http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html Mon, 27 Jul 2026 12:15:15 -0400 BRKR GRAL ILMN MDXH NEO NTRA PACB TECH TEM http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html <p>Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.</p><p>MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.</p><p>Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.</p><p>The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.</p> http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html Mon, 27 Jul 2026 12:15:15 -0400 BRKR GRAL ILMN MDXH NEO NTRA PACB TECH TEM http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html <p>Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.</p><p>MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.</p><p>Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.</p><p>The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.</p> http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html Mon, 27 Jul 2026 12:15:15 -0400 BRKR GRAL ILMN MDXH NEO NTRA PACB TECH TEM http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html <p>Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.</p><p>MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.</p><p>Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.</p><p>The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.</p> http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html Mon, 27 Jul 2026 12:15:15 -0400 BRKR GRAL ILMN MDXH NEO NTRA PACB TECH TEM http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html <p>Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.</p><p>MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.</p><p>Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.</p><p>The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.</p> http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html Mon, 27 Jul 2026 12:15:15 -0400 BRKR GRAL ILMN MDXH NEO NTRA PACB TECH TEM http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html <p>Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.</p><p>MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.</p><p>Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.</p><p>The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.</p> http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html Mon, 27 Jul 2026 12:15:15 -0400 BRKR GRAL ILMN MDXH NEO NTRA PACB TECH TEM http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html <p>Investing.com -- TD Cowen released short interest data for the life science and diagnostic tools industry on Friday, covering positions as of July 15.</p><p>MDxHealth (NASDAQ:MDXH), NeoGenomics (NASDAQ:NEO), Bruker Corporation (NASDAQ:BRKR), and Illumina (NASDAQ:ILMN) recorded the largest increases in short interest during the period.</p><p>Bio-Techne Corporation (NASDAQ:TECH), Tempus AI (NASDAQ:TEM), CAI International, and Natera (NASDAQ:NTRA) saw the largest declines in short interest.</p><p>The four most heavily shorted names in the sector are Whole Genome Sequencing company WGS, Grail (NASDAQ:GRAL), Tempus AI, and Pacific Biosciences (NASDAQ:PACB), according to TD Cowen.</p> http://www.streetinsider.com/General+News/TD+Cowen+reports+short+interest+changes+in+life+science+stocks/26818242.html Mon, 27 Jul 2026 12:15:15 -0400 BRKR GRAL ILMN MDXH NEO NTRA PACB TECH TEM http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++MDxHealth+SA++++++++++++++For%3A+Jul+24/26814416.html si-local-file:///var/storage/secattach/20260724/26814416.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++MDxHealth+SA++++++++++++++For%3A+Jul+24/26814416.html Fri, 24 Jul 2026 17:29:00 -0400 MDXH O.00953707 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++MDxHealth+SA++++++++++++++For%3A+Jul+24/26814416.html si-local-file:///var/storage/secattach/20260724/26814416.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++MDxHealth+SA++++++++++++++For%3A+Jul+24/26814416.html Fri, 24 Jul 2026 17:29:00 -0400 MDXH O.00953707 http://www.streetinsider.com/Press+Releases/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding++Minimum+Market+Value+of+Listed+Securities+Deficiency/26814173.html <p align="center"><b>Mdxhealth Announces Receipt of Nasdaq Notification Regarding </b><b>Minimum Market Value of Listed Securities Deficiency</b></p> <p align="justify">IRVINE, California – July 24, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a leader in urology-focused precision diagnostics, today announced that the Company received an additional notification letter (the “Additional Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) related to the recent reduction in the price for the Company’s ordinary shares. The initial notice, reported by the Company in its Form 6-K filed on July 2, 2026, related to the Company’s non-compliance with the $1.00 Minimum Bid Price requirement http://www.streetinsider.com/Press+Releases/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding++Minimum+Market+Value+of+Listed+Securities+Deficiency/26814173.html Fri, 24 Jul 2026 16:59:00 -0400 MDXH O.00953707 http://www.streetinsider.com/Press+Releases/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding++Minimum+Market+Value+of+Listed+Securities+Deficiency/26814173.html <p align="center"><b>Mdxhealth Announces Receipt of Nasdaq Notification Regarding </b><b>Minimum Market Value of Listed Securities Deficiency</b></p> <p align="justify">IRVINE, California – July 24, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a leader in urology-focused precision diagnostics, today announced that the Company received an additional notification letter (the “Additional Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) related to the recent reduction in the price for the Company’s ordinary shares. The initial notice, reported by the Company in its Form 6-K filed on July 2, 2026, related to the Company’s non-compliance with the $1.00 Minimum Bid Price requirement http://www.streetinsider.com/Press+Releases/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding++Minimum+Market+Value+of+Listed+Securities+Deficiency/26814173.html Fri, 24 Jul 2026 16:59:00 -0400 MDXH O.00953707 http://www.streetinsider.com/Globe+Newswire/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding++Minimum+Market+Value+of+Listed+Securities+Deficiency/26814173.html <p align="center"><b>Mdxhealth Announces Receipt of Nasdaq Notification Regarding </b><b>Minimum Market Value of Listed Securities Deficiency</b></p> <p align="justify">IRVINE, California – July 24, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a leader in urology-focused precision diagnostics, today announced that the Company received an additional notification letter (the “Additional Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) related to the recent reduction in the price for the Company’s ordinary shares. The initial notice, reported by the Company in its Form 6-K filed on July 2, 2026, related to the Company’s non-compliance with the $1.00 Minimum Bid Price requirement http://www.streetinsider.com/Globe+Newswire/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding++Minimum+Market+Value+of+Listed+Securities+Deficiency/26814173.html Fri, 24 Jul 2026 16:59:00 -0400 MDXH O.00953707 http://www.streetinsider.com/Globe+Newswire/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding++Minimum+Market+Value+of+Listed+Securities+Deficiency/26814173.html <p align="center"><b>Mdxhealth Announces Receipt of Nasdaq Notification Regarding </b><b>Minimum Market Value of Listed Securities Deficiency</b></p> <p align="justify">IRVINE, California – July 24, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a leader in urology-focused precision diagnostics, today announced that the Company received an additional notification letter (the “Additional Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) related to the recent reduction in the price for the Company’s ordinary shares. The initial notice, reported by the Company in its Form 6-K filed on July 2, 2026, related to the Company’s non-compliance with the $1.00 Minimum Bid Price requirement http://www.streetinsider.com/Globe+Newswire/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding++Minimum+Market+Value+of+Listed+Securities+Deficiency/26814173.html Fri, 24 Jul 2026 16:59:00 -0400 MDXH O.00953707 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++MDxHealth+SA+++++++++++++++++++++++++++Filed+by%3A+AWM+Investment+Company%2C+Inc./26747438.html si-local-file:///var/storage/secattach/20260708/26747438.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++MDxHealth+SA+++++++++++++++++++++++++++Filed+by%3A+AWM+Investment+Company%2C+Inc./26747438.html Wed, 08 Jul 2026 15:58:00 -0400 MDXH O.00953707 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++MDxHealth+SA+++++++++++++++++++++++++++Filed+by%3A+AWM+Investment+Company%2C+Inc./26747438.html si-local-file:///var/storage/secattach/20260708/26747438.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++MDxHealth+SA+++++++++++++++++++++++++++Filed+by%3A+AWM+Investment+Company%2C+Inc./26747438.html Wed, 08 Jul 2026 15:58:00 -0400 MDXH O.00953707 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++MDxHealth+SA++++++++++++++For%3A+Jul+02/26727964.html si-local-file:///var/storage/secattach/20260702/26727964.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++MDxHealth+SA++++++++++++++For%3A+Jul+02/26727964.html Thu, 02 Jul 2026 16:16:00 -0400 MDXH O.00953707 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++MDxHealth+SA++++++++++++++For%3A+Jul+02/26727964.html si-local-file:///var/storage/secattach/20260702/26727964.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++MDxHealth+SA++++++++++++++For%3A+Jul+02/26727964.html Thu, 02 Jul 2026 16:16:00 -0400 MDXH O.00953707 http://www.streetinsider.com/Corporate+News/Mdxhealth+receives+Nasdaq+minimum+bid+price+deficiency+notice/26727347.html <p>Mdxhealth SA (NASDAQ: MDXH) announced it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market, dated June 30, 2026, stating the company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.</p> <p>Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum closing bid price of at least $1.00 per share. A deficiency is triggered when a stock fails to meet this threshold for 30 consecutive business days.</p> <p>The notification does not affect the company's current listing status. Under Nasdaq Listing Rule 5810(c)(3)(A), the company has 180 calendar http://www.streetinsider.com/Corporate+News/Mdxhealth+receives+Nasdaq+minimum+bid+price+deficiency+notice/26727347.html Thu, 02 Jul 2026 16:00:16 -0400 MDXH O.00953707 http://www.streetinsider.com/Corporate+News/Mdxhealth+receives+Nasdaq+minimum+bid+price+deficiency+notice/26727347.html <p>Mdxhealth SA (NASDAQ: MDXH) announced it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market, dated June 30, 2026, stating the company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.</p> <p>Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum closing bid price of at least $1.00 per share. A deficiency is triggered when a stock fails to meet this threshold for 30 consecutive business days.</p> <p>The notification does not affect the company's current listing status. Under Nasdaq Listing Rule 5810(c)(3)(A), the company has 180 calendar http://www.streetinsider.com/Corporate+News/Mdxhealth+receives+Nasdaq+minimum+bid+price+deficiency+notice/26727347.html Thu, 02 Jul 2026 16:00:16 -0400 MDXH O.00953707 http://www.streetinsider.com/Press+Releases/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding+Minimum+Bid+Price+Deficiency/26727346.html <p align="justify"><b>IRVINE, California </b>– July 2, 2026 (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=HB3P7oW7Fp3jX58MabFEE0Vt2RMdOafSN8sKi0v0r5T92Pix1v3GBRTACjqc-2OwjCNvckCITLB0gybCeXwwX9HZrveYPIsPl5pAIvjnUQqGrCO8grypthyulOZfnNebhzEqhU1ZPRlAgJzMMuuVgw==" rel="nofollow" target="_blank">GlobeNewswire</a>) – Mdxhealth SA (NASDAQ: MDXH) (the &quot;Company&quot; or &quot;mdxhealth&quot;), a leader in urology-focused precision diagnostics, today announced that the Company received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated June 30, 2026, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure upon http://www.streetinsider.com/Press+Releases/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding+Minimum+Bid+Price+Deficiency/26727346.html Thu, 02 Jul 2026 16:00:00 -0400 MDXH O.00953707 http://www.streetinsider.com/Press+Releases/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding+Minimum+Bid+Price+Deficiency/26727346.html <p align="justify"><b>IRVINE, California </b>– July 2, 2026 (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=HB3P7oW7Fp3jX58MabFEE0Vt2RMdOafSN8sKi0v0r5T92Pix1v3GBRTACjqc-2OwjCNvckCITLB0gybCeXwwX9HZrveYPIsPl5pAIvjnUQqGrCO8grypthyulOZfnNebhzEqhU1ZPRlAgJzMMuuVgw==" rel="nofollow" target="_blank">GlobeNewswire</a>) – Mdxhealth SA (NASDAQ: MDXH) (the &quot;Company&quot; or &quot;mdxhealth&quot;), a leader in urology-focused precision diagnostics, today announced that the Company received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated June 30, 2026, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure upon http://www.streetinsider.com/Press+Releases/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding+Minimum+Bid+Price+Deficiency/26727346.html Thu, 02 Jul 2026 16:00:00 -0400 MDXH O.00953707 http://www.streetinsider.com/Globe+Newswire/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding+Minimum+Bid+Price+Deficiency/26727346.html <p align="justify"><b>IRVINE, California </b>– July 2, 2026 (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=HB3P7oW7Fp3jX58MabFEE0Vt2RMdOafSN8sKi0v0r5T92Pix1v3GBRTACjqc-2OwjCNvckCITLB0gybCeXwwX9HZrveYPIsPl5pAIvjnUQqGrCO8grypthyulOZfnNebhzEqhU1ZPRlAgJzMMuuVgw==" rel="nofollow" target="_blank">GlobeNewswire</a>) – Mdxhealth SA (NASDAQ: MDXH) (the &quot;Company&quot; or &quot;mdxhealth&quot;), a leader in urology-focused precision diagnostics, today announced that the Company received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated June 30, 2026, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure upon http://www.streetinsider.com/Globe+Newswire/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding+Minimum+Bid+Price+Deficiency/26727346.html Thu, 02 Jul 2026 16:00:00 -0400 MDXH O.00953707 http://www.streetinsider.com/Globe+Newswire/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding+Minimum+Bid+Price+Deficiency/26727346.html <p align="justify"><b>IRVINE, California </b>– July 2, 2026 (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=HB3P7oW7Fp3jX58MabFEE0Vt2RMdOafSN8sKi0v0r5T92Pix1v3GBRTACjqc-2OwjCNvckCITLB0gybCeXwwX9HZrveYPIsPl5pAIvjnUQqGrCO8grypthyulOZfnNebhzEqhU1ZPRlAgJzMMuuVgw==" rel="nofollow" target="_blank">GlobeNewswire</a>) – Mdxhealth SA (NASDAQ: MDXH) (the &quot;Company&quot; or &quot;mdxhealth&quot;), a leader in urology-focused precision diagnostics, today announced that the Company received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated June 30, 2026, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure upon http://www.streetinsider.com/Globe+Newswire/Mdxhealth+Announces+Receipt+of+Nasdaq+Notification+Regarding+Minimum+Bid+Price+Deficiency/26727346.html Thu, 02 Jul 2026 16:00:00 -0400 MDXH O.00953707